The size of the Asia-pacific Neuroprosthetics market was valued at USD 1.47 Billion in 2021. It is expected to grow at a CAGR of 14.92% to reach 2.95 Billion by 2026.
Availability of treatments across all the Asia countries and favorable reimbursement policies in government healthcare centers are majorly propelling the Asia Pacific neuroprosthetics market. Rising funds and investments from the government, rapid technological advancements, and Y-O-Y growth in the incidence of neurological diseases such as traumatic brain injury, stroke, and others drive the market.
Factors such as high prices, inadequate reimbursement policies in undeveloped countries, and unfavorable side-effects cause major restrains in the neuroprosthetics market growth in APAC. The increasing number of patients affected by Parkinson’s diseases is severely hindering the market, making a single complicated life. The scarcity of experienced professionals and adverse reimbursement schemes are likely to obstruct the market growth in APAC. Low acceptance and low awareness regarding the devices may restrict market growth.
This research report on the Asia Pacific neuroprosthetics market has been segmented and sub-segmented into the following categories:
Regional Analysis:
The Asia Pacific is anticipated to be the fastest-growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures and rising awareness levels amongst consumers.
Induction of international healthcare developments advancing safe and effective medical procedures and surging consciousness levels amid the consumers. China and India are expected to be the quickest growing markets in the region of APAC.
China is leading the Asia pacific neuroprosthetics market due to the increasing count of patients, rising awareness regarding the disease, and improving healthcare infrastructure. India is expected to grow with rapid growth in the region because of mental disorders and other neurological problems existing in the notable count in accelerating the market growth. An increasing number of accidents proceeding to uplifted amputation cases and a Y-O-Y growth in the prevalence of diabetes are accelerating the neuroprosthetics market growth.
Japan is expected to have notable growth during the forecast period due to the mounting number of hearing loss occurrences. Increasing healthcare awareness all over the region is likely to mount the development.
Notable companies leading in the APAC Neuroprosthetics Market profiled in the report are Cochlear Ltd., Boston Scientific Corporation, Cyberonics Inc., Medtronic plc, NDI Medical LLC, NeuroPace Inc., St. Jude Medical Inc., Nervo Corp., Retina Implant AG, Biomet Inc., and Sonova.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Motor Prosthetic
5.1.3 Auditory Prosthetics
5.1.4 Visual Prosthetics
5.1.5 Cognitive Prosthetics
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 Technology
5.2.1 Introduction
5.2.2 Deep Brain Stimulation
5.2.3 Vagus Nerve Stimulation
5.2.5 Spinal Cord Stimulation
5.2.6 Y-o-Y Growth Analysis, By Technology
5.2.7 Market Attractiveness Analysis, By Technology
5.2.8 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Motor Neuron Disorders
5.3.3 Physiological disorders
5.3.4 Cognitive disorders
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End-user
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Clinics
5.4.7 Y-o-Y Growth Analysis, By End-user
5.4.8 Market Attractiveness Analysis, By End-user
5.4.9 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End-user
6.1.5 Market Share Analysis
6.1.5.2 By Type
6.1.5.3 By Technolgy
6.1.5.4 By Application
6.1.5.5 By End-user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Cochlear Ltd
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cochlear Ltd
8.3 Boston Scientific Corporation
8.4 Cyberonics Inc
8.5 Medtronic plc
8.6 NDI Medical LLC
8.7 NeuroPace Inc
8.8 St. Jude Medical Inc.
8.9 Nervo Corp
8.10 Retina Implant AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
